For the year ending 2025-12-31, CALC has $13,591K in assets. $20,232K in debts. $11,520K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 11,520 | |||
| Short-term investments | 1,496 | |||
| Prepaid clinical trial expenses | 201 | |||
| Other prepaid expenses and current assets | 259 | |||
| Assets held for sale | 54 | |||
| Total current assets | 13,530 | |||
| Property and equipment, net | 50 | |||
| Other assets | 11 | |||
| Total assets | 13,591 | |||
| Accounts payable | 1,161 | |||
| Accrued clinical trial costs | 1,081 | |||
| Accrued expenses | 290 | |||
| Current portion, promissory note | 1,250 | |||
| Total current liabilities | 3,782 | |||
| Promissory note | 8,450 | |||
| Warrant liability | 8,000 | |||
| Total liabilities | 20,232 | |||
| Common stock, 0.0001 par value 500,000,000 shares authorized at december 31, 2025 and december 31, 2024, respectively 15,437,410 and 13,481,917, issued and outstanding at december 31, 2025 and december 31, 2024, respectively | 4 | |||
| Additional paid-in capital | 182,681 | |||
| Accumulated deficit | -189,326 | |||
| Accumulated other comprehensive income | 0 | |||
| Total stockholders' equity (deficit) | -6,641 | |||
| Total liabilities and stockholders' equity (deficit) | 13,591 | |||
CalciMedica, Inc. (CALC)
CalciMedica, Inc. (CALC)